Editorial Commentary
Pancreatic cancer patients with germline BRCA mutations can benefit from olaparib treatment
Translational Cancer Research
2020;
9
(4)
:2154-2156
.
(30 April 2020)
Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer
Translational Cancer Research
2020;
9
(4)
:2157-2160
.
(30 April 2020)
PI3K/AKT/mTOR pathway in tumor progression of oligodendrogliomas
Translational Cancer Research
2020;
9
(4)
:2161-2163
.
(30 April 2020)
Bevacizumab combined with chemotherapy in platinum-resistant ovarian cancer: beyond the AURELIA trial
Translational Cancer Research
2020;
9
(4)
:2164-2167
.
(30 April 2020)
CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer
Translational Cancer Research
2020;
9
(4)
:2168-2170
.
(30 April 2020)
Protein translation controlled by the androgen receptor in prostate cancer: a novel therapeutic option?
Translational Cancer Research
2020;
9
(4)
:2171-2174
.
(30 April 2020)
Single nucleotide polymorphisms as the new predictors of therapy decisions in gastroesophageal junction and gastric adenocarcinoma?
Translational Cancer Research
2020;
9
(4)
:2175-2177
.
(30 April 2020)
Original Article
Microbiome characteristics and Bifidobacterium longum in colorectal cancer patients pre- and post-chemotherapy
Translational Cancer Research
2020;
9
(4)
:2178-2190
.
(30 April 2020)
Clinical significance of serum cystatin C in early evaluation of renal impairment caused by chemotherapy in elderly patients
Translational Cancer Research
2020;
9
(4)
:2191-2199
.
(30 April 2020)
Overexpression of COX-2 and clinicopathological features of gastric cancer: a meta-analysis
Translational Cancer Research
2020;
9
(4)
:2200-2209
.
(30 April 2020)
Transurethral en bloc resection with monopolar current for non-muscle invasive bladder cancer based on TNM system
Translational Cancer Research
2020;
9
(4)
:2210-2219
.
(30 April 2020)
Progesterone receptor inhibits the proliferation and invasion of endometrial cancer cells by up regulating Krüppel-like factor 9
Translational Cancer Research
2020;
9
(4)
:2220-2230
.
(30 April 2020)
Exome sequencing identified six copy number variations as a prediction model for recurrence of primary prostate cancers with distinctive prognosis
Translational Cancer Research
2020;
9
(4)
:2231-2242
.
(30 April 2020)
LAMP1 is more sensitive than LAMP2 in predicting prognosis of esophageal squamous cell carcinoma
Translational Cancer Research
2020;
9
(4)
:2243-2248
.
(30 April 2020)
Analysis of factors related to N2- or N3-stage breast cancer associated with 1–2 positive sentinel lymph nodes in Chinese patients
Translational Cancer Research
2020;
9
(4)
:2249-2258
.
(30 April 2020)
A retrospective study comparing D1 limited lymph node dissection and D2 extended lymph node dissection for N3 gastric cancer
Translational Cancer Research
2020;
9
(4)
:2259-2266
.
(30 April 2020)
The effect of metastasis patterns on survival in male patients with different breast cancer subtypes: results from the Surveillance, Epidemiology, and End Results (SEER) database
Translational Cancer Research
2020;
9
(4)
:2267-2279
.
(30 April 2020)
“Prostate management” under MRI-guidance: 7 years of improvements
Translational Cancer Research
2020;
9
(4)
:2280-2286
.
(30 April 2020)
Long term results of different radiotherapy techniques and fractions for esophageal squamous cell carcinoma
Translational Cancer Research
2020;
9
(4)
:2287-2294
.
(30 April 2020)
Do statins improve the survival time after esophagectomy? —a propensity score matching study
Translational Cancer Research
2020;
9
(4)
:2295-2299
.
(30 April 2020)
The prognostic roles of red blood cell-associated indicators in patients with resectable gastric cancers
Translational Cancer Research
2020;
9
(4)
:2300-2311
.
(30 April 2020)
Screening key lncRNAs and mRNAs for left-sided and right-sided colon adenocarcinoma based on lncRNA-mRNA functional synergistic network
Translational Cancer Research
2020;
9
(4)
:2312-2325
.
(30 April 2020)
Nomograms to predict overall and cancer-specific survival in patients with penile cancer
Translational Cancer Research
2020;
9
(4)
:2326-2339
.
(30 April 2020)
B4GALNT1 enhances cell proliferation and growth in oral squamous cell carcinoma via p38 and JNK MAPK pathway
Translational Cancer Research
2020;
9
(4)
:2340-2348
.
(30 April 2020)
Ultrasound-guided secondary radiofrequency ablation combined with chemotherapy in gastric cancer with recurrent liver metastasis
Translational Cancer Research
2020;
9
(4)
:2349-2356
.
(30 April 2020)
Glassy cell carcinoma of cervix: an analysis for 20 cases and literatures review
Translational Cancer Research
2020;
9
(4)
:2357-2362
.
(30 April 2020)
GLUT1/3/4 as novel biomarkers for the prognosis of human breast cancer
Translational Cancer Research
2020;
9
(4)
:2363-2377
.
(30 April 2020)
Increased serum level of interleukin-6 correlates with negative prognostic factors in extranodal NK/T-cell lymphoma
Translational Cancer Research
2020;
9
(4)
:2378-2389
.
(30 April 2020)
Data independent acquisition-mass spectrometry (DIA-MS)-based comprehensive profiling of bone metastatic cancers revealed molecular fingerprints to assist clinical classifications for bone metastasis of unknown primary (BMUP)
Translational Cancer Research
2020;
9
(4)
:2390-2401
.
(30 April 2020)
Development and validation of a nomogram to predict survival in patients with metastatic testicular germ cell tumors
Translational Cancer Research
2020;
9
(4)
:2402-2415
.
(30 April 2020)
Low expression of citron kinase is associated with poor patient outcomes in hepatocellular carcinoma
Translational Cancer Research
2020;
9
(4)
:2416-2423
.
(30 April 2020)
The association between genomic variations and histological grade in hepatocellular carcinoma
Translational Cancer Research
2020;
9
(4)
:2424-2433
.
(30 April 2020)
Dynamic monitoring of serum soluble programmed cell death ligand 1 as a response predictor to chemotherapy in metastatic or recurrent gastrointestinal cancer
Translational Cancer Research
2020;
9
(4)
:2434-2448
.
(30 April 2020)
MAFA-AS1, a long non-coding RNA, predicts for poor survival of hepatocellular carcinoma
Translational Cancer Research
2020;
9
(4)
:2449-2459
.
(30 April 2020)
Prognostic significance of serum carcinoembryonic antigen and squamous cell carcinoma antigen in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy
Translational Cancer Research
2020;
9
(4)
:2460-2471
.
(30 April 2020)
High programmed death-ligand 1 expression is a poor prognostic indicator for esophageal squamous cell carcinoma and is correlated with two-field lymph node metastasis
Translational Cancer Research
2020;
9
(4)
:2472-2481
.
(30 April 2020)
Denosumab inhibits MCF-7 cell line-induced spontaneous osteoclastogenesis via the RANKL/MALAT1/miR-124 axis
Translational Cancer Research
2020;
9
(4)
:2482-2491
.
(30 April 2020)
Incidence, treatment, and survival analysis in mediastinal malignant teratoma population
Translational Cancer Research
2020;
9
(4)
:2492-2502
.
(30 April 2020)
Establishment of surface marker expression profiles for colorectal cancer stem cells under different conditions
Translational Cancer Research
2020;
9
(4)
:2503-2510
.
(30 April 2020)
Relationships of hepatitis B virus infection with clinicopathological features in breast cancer and survival outcomes in central China
Translational Cancer Research
2020;
9
(4)
:2511-2517
.
(30 April 2020)
Prognosis value of liver stiffness measurements by 2D-SWE in primary HBV-positive hepatocellular carcinoma following radiofrequency ablation
Translational Cancer Research
2020;
9
(4)
:2518-2526
.
(30 April 2020)
Construction of differentially expressed Her-2 related lncRNA-mRNA-miRNA ceRNA network in Her-2 positive breast cancer
Translational Cancer Research
2020;
9
(4)
:2527-2533
.
(30 April 2020)
Bone metabolism in Chinese patients after laparoscopic Roux-en-Y gastric bypass
Translational Cancer Research
2020;
9
(4)
:2534-2541
.
(30 April 2020)
Spred-3 mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line
Translational Cancer Research
2020;
9
(4)
:2542-2555
.
(30 April 2020)
Mortality from heart disease following radiotherapy in esophageal carcinoma: a retrospective cohort study in US SEER cancer registry
Translational Cancer Research
2020;
9
(4)
:2556-2564
.
(30 April 2020)
Prognosis of stage III cervical cancer: a two-way outcome study
Translational Cancer Research
2020;
9
(4)
:2565-2575
.
(30 April 2020)
Exosomal miR-29b from cancer-associated fibroblasts inhibits the migration and invasion of hepatocellular carcinoma cells
Translational Cancer Research
2020;
9
(4)
:2576-2587
.
(30 April 2020)
MAP kinase-interacting kinase 1 (MNK1) plays as a tumor suppressor in bladder cancer
Translational Cancer Research
2020;
9
(4)
:2588-2598
.
(30 April 2020)
Candidate genes for predicting the survival of patients with gastric cancer: a study based on The Cancer Genome Atlas (TCGA) database
Translational Cancer Research
2020;
9
(4)
:2599-2608
.
(30 April 2020)
NLRC5, a valuable marker for the diagnosis and prognostic assessment of hepatocellular carcinoma
Translational Cancer Research
2020;
9
(4)
:2609-2617
.
(30 April 2020)
Additional treatment prolonged survival of pulmonary artery sarcoma after surgical resection
Translational Cancer Research
2020;
9
(4)
:2618-2626
.
(30 April 2020)
The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis
Translational Cancer Research
2020;
9
(4)
:2627-2637
.
(30 April 2020)
Interaction between linc01615 and miR-491-5p regulates the survival and metastasis of colorectal cancer cells
Translational Cancer Research
2020;
9
(4)
:2638-2647
.
(30 April 2020)
COPB2 promotes metastasis and inhibits apoptosis of lung adenocarcinoma cells through functioning as a target of miR-216a-3p
Translational Cancer Research
2020;
9
(4)
:2648-2659
.
(30 April 2020)
Effects of Tra2-beta1 on proliferation, apoptosis, and metastasis of hypoxic endometrial carcinoma cell and its correlation with clinicopathological features
Translational Cancer Research
2020;
9
(4)
:2660-2671
.
(30 April 2020)
HAX-1 overexpression in gastric cancer promotes cell proliferation
Translational Cancer Research
2020;
9
(4)
:2672-2682
.
(30 April 2020)
Dendrobium officinalis inhibited tumor growth in non-small cell lung cancer
Translational Cancer Research
2020;
9
(4)
:2683-2691
.
(30 April 2020)
Epidemiology characteristics of ethnic minority colorectal cancer in Yunnan in Southwestern China
Translational Cancer Research
2020;
9
(4)
:2692-2700
.
(30 April 2020)
The risk of developing acute non-lymphocytic leukemia in women with breast cancer
Translational Cancer Research
2020;
9
(4)
:2701-2709
.
(30 April 2020)
Metallothionein 1M (MT1M) inhibits lung adenocarcinoma cell viability, migration, and expression of cell mobility-related proteins through MDM2/p53/MT1M signaling
Translational Cancer Research
2020;
9
(4)
:2710-2720
.
(30 April 2020)
IL-1β secreted by macrophage M2 promotes metastasis of osteosarcoma via NF-κB/miR-181α-5p/RASSF1A/Wnt pathway
Translational Cancer Research
2020;
9
(4)
:2721-2733
.
(30 April 2020)
Exploring metabolomics biomarkers for evaluating the effectiveness of concurrent radiochemotherapy for cervical cancers
Translational Cancer Research
2020;
9
(4)
:2734-2747
.
(30 April 2020)
Multiple roles of THY1 in gastric cancer based on data mining
Translational Cancer Research
2020;
9
(4)
:2748-2757
.
(30 April 2020)
A nomogram for predicting cancer-specific survival in different age groups for operable gastric cancer: a population-based study
Translational Cancer Research
2020;
9
(4)
:2758-2768
.
(30 April 2020)
Clinical outcomes of proximal gastrectomy versus total gastrectomy for locally advanced proximal gastric cancer: a propensity score matching analysis
Translational Cancer Research
2020;
9
(4)
:2769-2779
.
(30 April 2020)
Associations between polymorphisms in genes of base excision repair pathway and lung cancer risk
Translational Cancer Research
2020;
9
(4)
:2780-2800
.
(30 April 2020)
Higher T cell immunoglobulin mucin-3 (Tim-3) expression in cervical cancer is associated with a satisfactory prognosis
Translational Cancer Research
2020;
9
(4)
:2801-2813
.
(30 April 2020)
Evaluation of serum midkine and carcinoembryonic antigen as diagnostic biomarkers for rectal cancer and synchronous metastasis
Translational Cancer Research
2020;
9
(4)
:2814-2823
.
(30 April 2020)
Relationships between expression of glucose transporter protein-1 and hypoxia inducible factor-1α, prognosis and 18F-FDG uptake in laryngeal and hypopharyngeal carcinomas
Translational Cancer Research
2020;
9
(4)
:2824-2837
.
(30 April 2020)
MicroRNA-124 and microRNA-378 inhibit the proliferation and invasion of colorectal cancer by upregulating KiSS1
Translational Cancer Research
2020;
9
(4)
:2838-2846
.
(30 April 2020)
Secondary malignancies after radiation therapy in prostate cancer survivors: a propensity-score matched competing-risk analysis
Translational Cancer Research
2020;
9
(4)
:2847-2854
.
(30 April 2020)
Extracellular ubiquitin inhibits the apoptosis of hepatoma cells via the involvement of macrophages
Translational Cancer Research
2020;
9
(4)
:2855-2864
.
(30 April 2020)
Comparison of safety and efficacy between total endoscopic resection and conventional open surgery for malignant thyroid tumors: a meta-analysis
Translational Cancer Research
2020;
9
(4)
:2865-2874
.
(30 April 2020)
Pretreatment neutrophil-to-lymphocyte ratio is a predictive biomarker for EGFR TKI-treated patients with advanced EGFR- mutant Non-small cell lung cancer
Translational Cancer Research
2020;
9
(4)
:2875-2883
.
(30 April 2020)
Type 2 diabetes mellitus does not increase the risk of multiple myeloma: a systematic review and meta-analysis
Translational Cancer Research
2020;
9
(4)
:2884-2894
.
(30 April 2020)
Clinical management of vascular lake during transarterial chemoembolization with CalliSpheres drug-eluting beads (DEBs) for the treatment of hepatocellular carcinoma
Translational Cancer Research
2020;
9
(4)
:2895-2903
.
(30 April 2020)
Hypoxia induces tumor cell growth and angiogenesis in non-small cell lung carcinoma via the Akt-PDK1-HIF1α-YKL-40 pathway
Translational Cancer Research
2020;
9
(4)
:2904-2918
.
(30 April 2020)
Methylation of PLIN5 is a crucial biomarker and is involved in ovarian cancer development
Translational Cancer Research
2020;
9
(4)
:2919-2930
.
(30 April 2020)
miR-28-5p inhibits carcinogenesis in colon cancer cells and is necessary for erastin-induced ferroptosis
Translational Cancer Research
2020;
9
(4)
:2931-2940
.
(30 April 2020)
Brief Report
Metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth
Translational Cancer Research
2020;
9
(4)
:2941-2950
.
(30 April 2020)
Identification of an individualized autophagy prognostic index in clear cell renal cell carcinoma patients
Translational Cancer Research
2020;
9
(4)
:2951-2961
.
(30 April 2020)
Research Highlights
Optimization of internal reference genes for qPCR in human pancreatic cancer research
Translational Cancer Research
2020;
9
(4)
:2962-2971
.
(30 April 2020)
Review Article
Predicting response to radiotherapy in tumors with PET/CT: when and how?
Translational Cancer Research
2020;
9
(4)
:2972-2981
.
(30 April 2020)
EGFR exon 20 insertion mutations in non-small cell lung cancer
Translational Cancer Research
2020;
9
(4)
:2982-2991
.
(30 April 2020)
Case Report
Exploration of the genomic landscape of a long-term surviving stage III colorectal cancer patient identifies recurrent and rare mutations: a case report
Translational Cancer Research
2020;
9
(4)
:2992-2998
.
(30 April 2020)
Neurological paraneoplastic syndrome caused by small cell lung cancer: a case report
Translational Cancer Research
2020;
9
(4)
:2999-3002
.
(30 April 2020)
Long-term survival of an unresectable upper thoracic esophageal squamous cell carcinoma with severe dysphagia following nasogastric tube feeding and camrelizumab-containing therapy: a case report
Translational Cancer Research
2020;
9
(4)
:3003-3006
.
(30 April 2020)
Analysis of a pedigree of Peutz-Jeghers syndrome and RET proto-oncogene mutation: one case report and literature review
Translational Cancer Research
2020;
9
(4)
:3007-3011
.
(30 April 2020)
Pazopanib as salvage therapy in metastatic renal cell carcinoma with hypercalcemic crisis and renal insufficiency: a case report and literature review
Translational Cancer Research
2020;
9
(4)
:3012-3017
.
(30 April 2020)
Rectal metastasis from a previously resected carcinoma of the pancreas: a case report
Translational Cancer Research
2020;
9
(4)
:3018-3023
.
(30 April 2020)
Extrapancreatic solid pseudopapillary neoplasm: report of a unique case of primary posterior mediastinum origin and review of the literature
Translational Cancer Research
2020;
9
(4)
:3024-3029
.
(30 April 2020)
Neo-adjuvant chemotherapy followed by radical resection for primary borderline resectable unicentric Castleman disease: a case report
Translational Cancer Research
2020;
9
(4)
:3030-3033
.
(30 April 2020)
Sclerosing thymoma: a case report and literature review
Translational Cancer Research
2020;
9
(4)
:3034-3039
.
(30 April 2020)
Hereditary multiple exostoses complicated with lung cancer with cough as the first symptom: a case report
Translational Cancer Research
2020;
9
(4)
:3040-3046
.
(30 April 2020)
An operated case of locally advanced thymic atypical carcinoid in anterior mediastinum: a case report
Translational Cancer Research
2020;
9
(4)
:3047-3053
.
(30 April 2020)
A promising treatment option for refractory male primary choriocarcinoma: report of two cases
Translational Cancer Research
2020;
9
(4)
:3054-3060
.
(30 April 2020)
Cerebral metastases of parathyroid carcinoma: a case report and literature review
Translational Cancer Research
2020;
9
(4)
:3061-3066
.
(30 April 2020)
Postoperative diffused alveolar hemorrhage complicated by pneumonia after lung cancer surgery in a patient with liver cirrhosis: a case report and review of literatures
Translational Cancer Research
2020;
9
(4)
:3067-3072
.
(30 April 2020)
Editorial on Oral Pre-cancer and Cancer
Preface to the series on oral pre-cancer and cancer
Translational Cancer Research
2020;
9
(4)
:3073-3075
.
(30 April 2020)
Original Article on Oral Pre-cancer and Cancer
The natural history of oral mucosal lesions with both lichenoid and epithelial dysplastic features: a systematic review
Translational Cancer Research
2020;
9
(4)
:3076-3083
.
(30 April 2020)
Serum uric acid levels in patients with oral cancer, leukoplakia and submucous fibrosis: a cross-sectional study
Translational Cancer Research
2020;
9
(4)
:3084-3091
.
(30 April 2020)
Assessing the potential association between Epstein-Barr virus and oral squamous cell carcinoma: a systematic review and meta- analysis
Translational Cancer Research
2020;
9
(4)
:3092-3100
.
(30 April 2020)
Histomorphometric comparative analysis between the oral mucosa of fibrous inflammatory hyperplasia and oral leukoplakia
Translational Cancer Research
2020;
9
(4)
:3101-3106
.
(30 April 2020)
Effect of prosthetic rehabilitation on oral health-related quality of life of patients with head and neck cancer: a systematic review
Translational Cancer Research
2020;
9
(4)
:3107-3118
.
(30 April 2020)
Assessing the nature of the association of human papillomavirus in oral cancer with and without known risk factors
Translational Cancer Research
2020;
9
(4)
:3119-3125
.
(30 April 2020)
Review Article on Oral Pre-cancer and Cancer
Impact of oral mucositis on quality of life in patients undergoing oncological treatment: a systematic review
Translational Cancer Research
2020;
9
(4)
:3126-3134
.
(30 April 2020)
CRISPR-Cas genome editing tool: a narrow lane of cancer therapeutics with potential blockades
Translational Cancer Research
2020;
9
(4)
:3135-3141
.
(30 April 2020)
Reviewing the oral carcinogenic potential of E-cigarettes using the Bradford Hill criteria of causation
Translational Cancer Research
2020;
9
(4)
:3142-3152
.
(30 April 2020)
Does microbiome shift play a role in carcinogenesis? A systematic review
Translational Cancer Research
2020;
9
(4)
:3153-3166
.
(30 April 2020)
